Key points
- Net loss of $4,103,426, down from $5,039,080 in FY2025
- Revenue increased to $274,400 from $270,730
- Cash reserves grew to $1,178,505
- Significant commercial agreements signed in Australia, Europe, UK, MENA, India, Japan, Vietnam, and Thailand
- Audit report includes a material uncertainty related to going concern
Full summary
Memphasys Ltd. reported its financial results for the year ended 30 June 2026, showing a net loss of $4,103,426, down from $5,039,080 in the previous year. Revenue increased to $274,400 from $270,730. The company's cash reserves grew to $1,178,505, up from $298,302. The company achieved significant commercial progress, signing agreements in Australia, Europe, the UK, MENA, India, Japan, Vietnam, and Thailand. Despite the loss, the company is well-positioned to accelerate global commercialization and build a scalable, recurring revenue business. The independent audit report includes a material uncertainty related to going concern.
Guidance
Memphasys Ltd. expects contracted FY2026 sales of A$3 million, exceeding the A$2 million target.
Outlook
Memphasys Ltd. is well positioned to accelerate global commercialization and build a scalable, recurring revenue business with regulatory approvals anticipated in Vietnam, Turkey, and India.